EQ CIK: 1746466

Equillium, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.1
FY22:
−8.73
FY23:
−21.8
FY24:
−19.0
FY25:
−22.7
Change from FY21 to FY25
millions USD
FY21:
27.4
FY22:
18.7
FY23:
−4.76
FY24:
13.8
FY25:
4.46
Change from FY21 to FY25
millions USD
FY21:
31.1
FY22:
−1.22
FY23:
−9.23
FY24:
0.16
FY25:
30.4
millions USD
FY21:
26.4
FY22:
8.74
FY23:
−35.9
FY24:
−5.13
FY25:
12.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.1
FY22:
−9.01
FY23:
−21.8
FY24:
−19.1
FY25:
−22.8

All amounts in millions USD Data source:SEC EDGAR